{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:56:50Z","timestamp":1772308610068,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/DTP-FTO\/1018\/2014"],"award-info":[{"award-number":["PTDC\/DTP-FTO\/1018\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of cannabinoids to treat fibrotic skin diseases is an emergent issue. Therefore, we aimed to evaluate systemic and skin endocannabinoid responses in the wound-healing process in humans. A prospective study was performed in 50 patients who underwent body-contouring surgery. Anandamide (<jats:italic>N<\/jats:italic>-arachidonoylethanolamine, AEA), 2-arachidonoylglycerol (2-AG), palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) were quantified using LC\u2013MS\/MS. Ten (20%) patients developed hypertrophic (HT) scars. No significant changes were observed between the normal (N) scar and HT scar groups in terms of plasma and skin endocannabinoids. Nevertheless, a positive correlation between plasma and skin AEA concentrations was found in the N group (r\u2009=\u20090.38, <jats:italic>p<\/jats:italic>\u2009=\u20090.015), which was absent in the HT group. Moreover, the AEA concentration was significantly lower in HT scar tissue than in normal scar tissue (0.77\u2009\u00b1\u20090.12\u00a0ng\/g vs 1.15\u2009\u00b1\u20090.15\u00a0ng\/g, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Interestingly, in all patients, the surgical intervention produced a time-dependent effect with a U shape for AEA, PEA and OEA plasma concentrations. In contrast, 2-AG plasma concentrations increased 5\u00a0days after surgery and were reduced and stabilized 3\u00a0months later. These results suggest crosstalk between systemic and local skin endocannabinoid systems during human wound healing. AEA appears to be the most likely candidate for this link, which is deficient in patients with HT scars.<\/jats:p>","DOI":"10.1038\/s41598-020-68058-3","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T10:04:08Z","timestamp":1594116248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing"],"prefix":"10.1038","volume":"10","author":[{"given":"In\u00eas B.","family":"Correia-S\u00e1","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia M.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Paula V.","family":"Serr\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ana I.","family":"Loureiro","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Fernandes-Lopes","sequence":"additional","affiliation":[]},{"given":"Marisa","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Maria A.","family":"Vieira-Coelho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"68058_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561\u2013564. https:\/\/doi.org\/10.1038\/346561a0 (1990).","journal-title":"Nature"},{"issue":"Suppl 1","key":"68058_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","volume":"20","author":"K Mackie","year":"2008","unstructured":"Mackie, K. Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol. 20(Suppl 1), 10\u201314. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01671.x (2008).","journal-title":"J. Neuroendocrinol."},{"key":"68058_CR3","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946\u20131949. https:\/\/doi.org\/10.1126\/science.1470919 (1992).","journal-title":"Science"},{"key":"68058_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura, T. et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89\u201397. https:\/\/doi.org\/10.1006\/bbrc.1995.2437 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"68058_CR5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/0929867306666220401141630","volume":"6","author":"V Di Marzo","year":"1999","unstructured":"Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D. & Martin, B. R. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Curr. Med. Chem. 6, 721\u2013744 (1999).","journal-title":"Curr. Med. Chem."},{"key":"68058_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353","volume":"67","author":"J Lo Verme","year":"2005","unstructured":"Lo Verme, J. et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67, 15\u201319. https:\/\/doi.org\/10.1124\/mol.104.006353 (2005).","journal-title":"Mol. Pharmacol."},{"key":"68058_CR7","doi-asserted-by":"publisher","first-page":"27849","DOI":"10.1074\/jbc.M404087200","volume":"279","author":"M Guzman","year":"2004","unstructured":"Guzman, M. et al. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279, 27849\u201327854. https:\/\/doi.org\/10.1074\/jbc.M404087200 (2004).","journal-title":"J. Biol. Chem."},{"key":"68058_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tem.2015.07.007","volume":"26","author":"W Mazier","year":"2015","unstructured":"Mazier, W., Saucisse, N., Gatta-Cherifi, B. & Cota, D. The Endocannabinoid system: pivotal orchestrator of obesity and metabolic disease. Trends Endocrinol. Metab. 26, 524\u2013537. https:\/\/doi.org\/10.1016\/j.tem.2015.07.007 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"68058_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1249\/MSS.0000000000001276","volume":"49","author":"AG Brellenthin","year":"2017","unstructured":"Brellenthin, A. G., Crombie, K. M., Hillard, C. J. & Koltyn, K. F. Endocannabinoid and mood responses to exercise in adults with varying activity levels. Med. Sci. Sports Exerc. 49, 1688\u20131696. https:\/\/doi.org\/10.1249\/MSS.0000000000001276 (2017).","journal-title":"Med. Sci. Sports Exerc."},{"key":"68058_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/dmrr.764","volume":"23","author":"D Cota","year":"2007","unstructured":"Cota, D. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes Metab. Res. Rev. 23, 507\u2013517. https:\/\/doi.org\/10.1002\/dmrr.764 (2007).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"68058_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1172\/JCI17725","volume":"112","author":"D Cota","year":"2003","unstructured":"Cota, D. et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 112, 423\u2013431. https:\/\/doi.org\/10.1172\/JCI17725 (2003).","journal-title":"J. Clin. Invest."},{"key":"68058_CR12","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1046\/j.1365-2044.2001.02269.x","volume":"56","author":"RN Kumar","year":"2001","unstructured":"Kumar, R. N., Chambers, W. A. & Pertwee, R. G. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 56, 1059\u20131068. https:\/\/doi.org\/10.1046\/j.1365-2044.2001.02269.x (2001).","journal-title":"Anaesthesia"},{"key":"68058_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","volume":"168","author":"RG Pertwee","year":"2005","unstructured":"Pertwee, R. G. Pharmacological actions of cannabinoids. Handb. Exp. Pharmacol. 168, 1\u201351. https:\/\/doi.org\/10.1007\/3-540-26573-2_1 (2005).","journal-title":"Handb. Exp. Pharmacol."},{"key":"68058_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard, C. J. Circulating endocannabinoids: from whence do they come and where are they going?. Neuropsychopharmacology 43, 155\u2013172. https:\/\/doi.org\/10.1038\/npp.2017.130 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"68058_CR15","doi-asserted-by":"publisher","first-page":"e42399","DOI":"10.1371\/journal.pone.0042399","volume":"7","author":"I Matias","year":"2012","unstructured":"Matias, I. et al. Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS ONE 7, e42399. https:\/\/doi.org\/10.1371\/journal.pone.0042399 (2012).","journal-title":"PLoS ONE"},{"key":"68058_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/FTD.0b013e3182953e43","volume":"35","author":"A Krumbholz","year":"2013","unstructured":"Krumbholz, A., Anielski, P., Reisch, N., Schelling, G. & Thieme, D. Diagnostic value of concentration profiles of glucocorticosteroids and endocannabinoids in hair. Ther. Drug Monit. 35, 600\u2013607. https:\/\/doi.org\/10.1097\/FTD.0b013e3182953e43 (2013).","journal-title":"Ther. Drug Monit."},{"key":"68058_CR17","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/j.jchromb.2010.09.024","volume":"878","author":"AA Amoako","year":"2010","unstructured":"Amoako, A. A. et al. Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878, 3231\u20133237. https:\/\/doi.org\/10.1016\/j.jchromb.2010.09.024 (2010).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"68058_CR18","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00216-010-4103-z","volume":"398","author":"PM Lam","year":"2010","unstructured":"Lam, P. M., Marczylo, T. H. & Konje, J. C. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 398, 2089\u20132097. https:\/\/doi.org\/10.1007\/s00216-010-4103-z (2010).","journal-title":"Anal. Bioanal. Chem."},{"key":"68058_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI16116","volume":"111","author":"ML Casanova","year":"2003","unstructured":"Casanova, M. L. et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Invest. 111, 43\u201350. https:\/\/doi.org\/10.1172\/JCI16116 (2003).","journal-title":"J. Clin. Invest."},{"key":"68058_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jdermsci.2005.01.007","volume":"38","author":"S Stander","year":"2005","unstructured":"Stander, S., Schmelz, M., Metze, D., Luger, T. & Rukwied, R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci. 38, 177\u2013188. https:\/\/doi.org\/10.1016\/j.jdermsci.2005.01.007 (2005).","journal-title":"J. Dermatol. Sci."},{"key":"68058_CR21","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1073\/pnas.0409888102","volume":"102","author":"MM Ibrahim","year":"2005","unstructured":"Ibrahim, M. M. et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc.Natl. Acad. Sci. USA 102, 3093\u20133098. https:\/\/doi.org\/10.1073\/pnas.0409888102 (2005).","journal-title":"Proc.Natl. Acad. Sci. USA"},{"key":"68058_CR22","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1096\/fj.06-6638fje","volume":"20","author":"C Blazquez","year":"2006","unstructured":"Blazquez, C. et al. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J. 20, 2633\u20132635. https:\/\/doi.org\/10.1096\/fj.06-6638fje (2006).","journal-title":"FASEB J."},{"key":"68058_CR23","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1126\/science.1142265","volume":"316","author":"M Karsak","year":"2007","unstructured":"Karsak, M. et al. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316, 1494\u20131497. https:\/\/doi.org\/10.1126\/science.1142265 (2007).","journal-title":"Science"},{"key":"68058_CR24","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1096\/fj.06-7689com","volume":"21","author":"A Telek","year":"2007","unstructured":"Telek, A. et al. Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J. 21, 3534\u20133541. https:\/\/doi.org\/10.1096\/fj.06-7689com (2007).","journal-title":"FASEB J."},{"key":"68058_CR25","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1096\/fj.07-104877","volume":"22","author":"N Dobrosi","year":"2008","unstructured":"Dobrosi, N. et al. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J. 22, 3685\u20133695. https:\/\/doi.org\/10.1096\/fj.07-104877 (2008).","journal-title":"FASEB J."},{"key":"68058_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","volume":"30","author":"T Biro","year":"2009","unstructured":"Biro, T., Toth, B. I., Hasko, G., Paus, R. & Pacher, P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol. Sci. 30, 411\u2013420. https:\/\/doi.org\/10.1016\/j.tips.2009.05.004 (2009).","journal-title":"Trends Pharmacol. Sci."},{"key":"68058_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00403-011-1126-z","volume":"303","author":"S Magina","year":"2011","unstructured":"Magina, S. et al. Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect. Arch. Dermatol. Res. 303, 201\u2013210. https:\/\/doi.org\/10.1007\/s00403-011-1126-z (2011).","journal-title":"Arch. Dermatol. Res."},{"key":"68058_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/15569527.2016.1169541","volume":"36","author":"R Inci","year":"2017","unstructured":"Inci, R. et al. Dermatological aspects of synthetic cannabinoid addiction. Cutan. Ocul. Toxicol. 36, 125\u2013131. https:\/\/doi.org\/10.3109\/15569527.2016.1169541 (2017).","journal-title":"Cutan. Ocul. Toxicol."},{"key":"68058_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24050918","author":"KF Toth","year":"2019","unstructured":"Toth, K. F., Adam, D., Biro, T. & Olah, A. Cannabinoid signaling in the skin: therapeutic potential of the \u201cc(ut)annabinoid\u201d system. Molecules https:\/\/doi.org\/10.3390\/molecules24050918 (2019).","journal-title":"Molecules"},{"key":"68058_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/art.24395","volume":"60","author":"A Akhmetshina","year":"2009","unstructured":"Akhmetshina, A. et al. The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis Rheum. 60, 1129\u20131136. https:\/\/doi.org\/10.1002\/art.24395 (2009).","journal-title":"Arthritis Rheum."},{"key":"68058_CR31","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1002\/art.27642","volume":"62","author":"S Marquart","year":"2010","unstructured":"Marquart, S. et al. Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis. Arthritis Rheum. 62, 3467\u20133476. https:\/\/doi.org\/10.1002\/art.27642 (2010).","journal-title":"Arthritis Rheum."},{"key":"68058_CR32","first-page":"241","volume":"26","author":"ZB Zhao","year":"2010","unstructured":"Zhao, Z. B. et al. Expression of cannabinoid receptor I during mice skin incised wound healing course. Fa Yi Xue Za Zhi 26, 241\u2013245 (2010).","journal-title":"Fa Yi Xue Za Zhi"},{"key":"68058_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00414-012-0741-3","volume":"126","author":"JL Zheng","year":"2012","unstructured":"Zheng, J. L. et al. Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing in mice. Int. J .Legal Med. 126, 807\u2013814. https:\/\/doi.org\/10.1007\/s00414-012-0741-3 (2012).","journal-title":"Int. J .Legal Med."},{"key":"68058_CR34","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1111\/pde.13545","volume":"35","author":"MP Chelliah","year":"2018","unstructured":"Chelliah, M. P., Zinn, Z., Khuu, P. & Teng, J. M. C. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa. Pediatr. Dermatol. 35, e224\u2013e227. https:\/\/doi.org\/10.1111\/pde.13545 (2018).","journal-title":"Pediatr. Dermatol."},{"key":"68058_CR35","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.7417\/CT.2019.2116","volume":"170","author":"B Palmieri","year":"2019","unstructured":"Palmieri, B., Laurino, C. & Vadala, M. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clin. Ther. 170, e93\u2013e99. https:\/\/doi.org\/10.7417\/CT.2019.2116 (2019).","journal-title":"Clin. Ther."},{"issue":"Suppl 1","key":"68058_CR36","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","volume":"43","author":"B Berman","year":"2017","unstructured":"Berman, B., Maderal, A. & Raphael, B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol. Surg. 43(Suppl 1), S3\u2013S18. https:\/\/doi.org\/10.1097\/DSS.0000000000000819 (2017).","journal-title":"Dermatol. Surg."},{"key":"68058_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/s0039-6109(16)40983-7","volume":"56","author":"JA Schilling","year":"1976","unstructured":"Schilling, J. A. Wound healing. Surg. Clin. N. Am. 56, 859\u2013874. https:\/\/doi.org\/10.1016\/s0039-6109(16)40983-7 (1976).","journal-title":"Surg. Clin. N. Am."},{"key":"68058_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/10253890.2018.1451837","volume":"21","author":"K Wingenfeld","year":"2018","unstructured":"Wingenfeld, K. et al. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder\u2014a pilot study. Stress 21, 366\u2013369. https:\/\/doi.org\/10.1080\/10253890.2018.1451837 (2018).","journal-title":"Stress"},{"key":"68058_CR39","doi-asserted-by":"publisher","first-page":"104471","DOI":"10.1016\/j.psyneuen.2019.104471","volume":"111","author":"EC Hanlon","year":"2020","unstructured":"Hanlon, E. C. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology 111, 104471. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104471 (2020).","journal-title":"Psychoneuroendocrinology"},{"key":"68058_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.12659\/MSMBR.914019","volume":"25","author":"T Ayakannu","year":"2019","unstructured":"Ayakannu, T., Taylor, A. H., Marczylo, T. H. & Konje, J. C. New insights of uterine leiomyoma pathogenesis: endocannabinoid system. Med. Sci. Monit. Basic Res. 25, 76\u201387. https:\/\/doi.org\/10.12659\/MSMBR.914019 (2019).","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"68058_CR41","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3892\/ol.2019.10399","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang, J., Tian, Y., Zheng, R., Li, L. & Qiu, F. Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma. Oncol. Lett. 18, 1530\u20131538. https:\/\/doi.org\/10.3892\/ol.2019.10399 (2019).","journal-title":"Oncol. Lett."},{"key":"68058_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41387-017-0016-7","volume":"8","author":"HJ van Eyk","year":"2018","unstructured":"van Eyk, H. J. et al. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes. Nutr. Diabetes 8, 6. https:\/\/doi.org\/10.1038\/s41387-017-0016-7 (2018).","journal-title":"Nutr. Diabetes"},{"key":"68058_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2014.02.011","author":"AI Arno","year":"2014","unstructured":"Arno, A. I., Gauglitz, G. G., Barret, J. P. & Jeschke, M. G. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns https:\/\/doi.org\/10.1016\/j.burns.2014.02.011 (2014).","journal-title":"Burns"},{"key":"68058_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/path.1502","volume":"202","author":"FB Niessen","year":"2004","unstructured":"Niessen, F. B., Schalkwijk, J., Vos, H. & Timens, W. Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells. J. Pathol. 202, 121\u2013129. https:\/\/doi.org\/10.1002\/path.1502 (2004).","journal-title":"J. Pathol."},{"key":"68058_CR45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0305-4179(97)00070-3","volume":"23","author":"C Castagnoli","year":"1997","unstructured":"Castagnoli, C. et al. Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 23, 565\u2013572. https:\/\/doi.org\/10.1016\/s0305-4179(97)00070-3 (1997).","journal-title":"Burns"},{"key":"68058_CR46","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","volume":"97","author":"C Turcotte","year":"2015","unstructured":"Turcotte, C., Chouinard, F., Lefebvre, J. S. & Flamand, N. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. J. Leukoc. Biol. 97, 1049\u20131070. https:\/\/doi.org\/10.1189\/jlb.3RU0115-021R (2015).","journal-title":"J. Leukoc. Biol."},{"key":"68058_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/exd.12930","volume":"25","author":"A Olah","year":"2016","unstructured":"Olah, A. et al. Inhibition of fatty acid amide hydrolase exerts cutaneous anti-inflammatory effects both in vitro and in vivo. Exp. Dermatol. 25, 328\u2013330. https:\/\/doi.org\/10.1111\/exd.12930 (2016).","journal-title":"Exp. Dermatol."},{"key":"68058_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt, B. F. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83\u201387. https:\/\/doi.org\/10.1038\/384083a0 (1996).","journal-title":"Nature"},{"key":"68058_CR49","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.4049\/jimmunol.1500546","volume":"197","author":"V Chiurchiu","year":"2016","unstructured":"Chiurchiu, V. et al. Anandamide suppresses proinflammatory T cell responses in vitro through type-1 cannabinoid receptor-mediated mTOR inhibition in human keratinocytes. J. Immunol. 197, 3545\u20133553. https:\/\/doi.org\/10.4049\/jimmunol.1500546 (2016).","journal-title":"J. Immunol."},{"key":"68058_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2015.10.001","volume":"125","author":"CJ Hillard","year":"2015","unstructured":"Hillard, C. J. The endocannabinoid signaling system in the CNS: a primer. Int .Rev. Neurobiol. 125, 1\u201347. https:\/\/doi.org\/10.1016\/bs.irn.2015.10.001 (2015).","journal-title":"Int .Rev. Neurobiol."},{"key":"68058_CR51","doi-asserted-by":"publisher","first-page":"35552","DOI":"10.1074\/jbc.M106261200","volume":"276","author":"N Ueda","year":"2001","unstructured":"Ueda, N., Yamanaka, K. & Yamamoto, S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J. Biol. Chem. 276, 35552\u201335557. https:\/\/doi.org\/10.1074\/jbc.M106261200 (2001).","journal-title":"J. Biol. Chem."},{"key":"68058_CR52","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","volume":"14","author":"JL Blankman","year":"2007","unstructured":"Blankman, J. L., Simon, G. M. & Cravatt, B. F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347\u20131356. https:\/\/doi.org\/10.1016\/j.chembiol.2007.11.006 (2007).","journal-title":"Chem. Biol."},{"key":"68058_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bja\/aeq117","volume":"105","author":"F Weis","year":"2010","unstructured":"Weis, F. et al. Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. Br. J. Anaesth. 105, 139\u2013144. https:\/\/doi.org\/10.1093\/bja\/aeq117 (2010).","journal-title":"Br. J. Anaesth."},{"key":"68058_CR54","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.2337\/db06-0812","volume":"55","author":"M Bluher","year":"2006","unstructured":"Bluher, M. et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55, 3053\u20133060. https:\/\/doi.org\/10.2337\/db06-0812 (2006).","journal-title":"Diabetes"},{"key":"68058_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1194\/jlr.M021378","volume":"53","author":"F Fanelli","year":"2012","unstructured":"Fanelli, F. et al. Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC\/MS\/MS. J. Lipid Res. 53, 481\u2013493. https:\/\/doi.org\/10.1194\/jlr.M021378 (2012).","journal-title":"J. Lipid Res."},{"key":"68058_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","volume":"52","author":"V Di Marzo","year":"2009","unstructured":"Di Marzo, V. et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 52, 213\u2013217. https:\/\/doi.org\/10.1007\/s00125-008-1178-6 (2009).","journal-title":"Diabetologia"},{"key":"68058_CR57","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/npp.2012.100","volume":"37","author":"A Dlugos","year":"2012","unstructured":"Dlugos, A., Childs, E., Stuhr, K. L., Hillard, C. J. & de Wit, H. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 37, 2416\u20132427. https:\/\/doi.org\/10.1038\/npp.2012.100 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"68058_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","volume":"51","author":"D Cota","year":"2006","unstructured":"Cota, D., Tschop, M. H., Horvath, T. L. & Levine, A. S. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res. Rev. 51, 85\u2013107. https:\/\/doi.org\/10.1016\/j.brainresrev.2005.10.004 (2006).","journal-title":"Brain Res. Rev."},{"key":"68058_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-2007-993211","volume":"41","author":"MN Hill","year":"2008","unstructured":"Hill, M. N., Miller, G. E., Ho, W. S., Gorzalka, B. B. & Hillard, C. J. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 41, 48\u201353. https:\/\/doi.org\/10.1055\/s-2007-993211 (2008).","journal-title":"Pharmacopsychiatry"},{"key":"68058_CR60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq058","volume":"17","author":"T Karasu","year":"2011","unstructured":"Karasu, T., Marczylo, T. H., Maccarrone, M. & Konje, J. C. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Hum. Reprod. Update 17, 347\u2013361. https:\/\/doi.org\/10.1093\/humupd\/dmq058 (2011).","journal-title":"Hum. Reprod. Update"},{"key":"68058_CR61","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd1495","volume":"3","author":"V Di Marzo","year":"2004","unstructured":"Di Marzo, V., Bifulco, M. & De Petrocellis, L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3, 771\u2013784. https:\/\/doi.org\/10.1038\/nrd1495 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68058_CR62","first-page":"1273","volume":"17","author":"E Robinson","year":"2018","unstructured":"Robinson, E., Murphy, E. & Friedman, A. Knowledge, attitudes, and perceptions of cannabinoids in the dermatology community. J. Drugs Dermatol. 17, 1273\u20131278 (2018).","journal-title":"J. Drugs Dermatol."},{"key":"68058_CR63","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.burns.2015.04.018","volume":"41","author":"CM Thompson","year":"2015","unstructured":"Thompson, C. M., Sood, R. F., Honari, S., Carrougher, G. J. & Gibran, N. S. What score on the Vancouver Scar Scale constitutes a hypertrophic scar? Results from a survey of North American burn-care providers. Burns 41, 1442\u20131448. https:\/\/doi.org\/10.1016\/j.burns.2015.04.018 (2015).","journal-title":"Burns"},{"key":"68058_CR64","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.jchromb.2009.05.043","volume":"877","author":"J Palandra","year":"2009","unstructured":"Palandra, J., Prusakiewicz, J., Ozer, J. S., Zhang, Y. & Heath, T. G. Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization. J. Chromatogr B Anal. Technol. Biomed. Life Sci. 877, 2052\u20132060. https:\/\/doi.org\/10.1016\/j.jchromb.2009.05.043 (2009).","journal-title":"J. Chromatogr B Anal. Technol. Biomed. Life Sci."},{"key":"68058_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.talanta.2018.09.088","volume":"193","author":"LS Castillo-Peinado","year":"2019","unstructured":"Castillo-Peinado, L. S., Lopez-Bascon, M. A., Mena-Bravo, A., Luque de Castro, M. D. & Priego-Capote, F. Determination of primary fatty acid amides in different biological fluids by LC-MS\/MS in MRM mode with synthetic deuterated standards: Influence of biofluid matrix on sample preparation. Talanta 193, 29\u201336. https:\/\/doi.org\/10.1016\/j.talanta.2018.09.088 (2019).","journal-title":"Talanta"},{"key":"68058_CR66","doi-asserted-by":"publisher","first-page":"680867","DOI":"10.1155\/2015\/680867","volume":"2015","author":"A Mallipedhi","year":"2015","unstructured":"Mallipedhi, A. et al. Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis. J. Diabetes Res. 2015, 680867. https:\/\/doi.org\/10.1155\/2015\/680867 (2015).","journal-title":"J. Diabetes Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68058-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:48:47Z","timestamp":1670334527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68058"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68058-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"24 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11134"}}